These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8353798)

  • 1. Angiotensin converting enzyme inhibition: pharmacologic management to minimize postinfarction heart failure.
    Bridges J; Strong A
    Crit Care Nurs Q; 1993 Aug; 16(2):17-26. PubMed ID: 8353798
    [No Abstract]   [Full Text] [Related]  

  • 2. Indications for immediate angiotensin-converting enzyme inhibition in patients with acute myocardial infarction.
    LeJemtel TH; Hochman JS; Sonnenblick EH
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):47S-51S. PubMed ID: 7775715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of postinfarction cardiac insufficiency: role of angiotensin converting enzyme inhibitors].
    Guéret P; Cohen-Solal A; Bensaid J
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1709-16. PubMed ID: 1304144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors: congestive heart failure and beyond.
    Lombardi WL; Litwin SE
    Coron Artery Dis; 1999 Sep; 10(6):361-8. PubMed ID: 10474785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
    Weir R; McMurray JJ
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correction of postinfarction remodelling of the heart with angiotensin-converting enzyme inhibitors].
    Giliarevskiĭ SR; Orlov VA; Gvindzhiliia TV
    Kardiologiia; 1993; 33(12):37-47. PubMed ID: 8196256
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibition therapy following myocardial infarction. Rationale for clinical trials.
    Pfeffer MA
    Herz; 1991 Sep; 16 Spec No 1():278-82. PubMed ID: 1840297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease].
    Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A
    Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of ACE inhibitors and angiotensin receptor blockers in the treatment and prevention of chronic heart failure].
    Kárpáti P
    Orv Hetil; 2005 May; 146(18):827-31. PubMed ID: 15926627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of angiotensin-converting enzyme inhibitors in the treatment and prevention of congestive heart failure.
    Toher CA; Francis GS
    Coron Artery Dis; 1993 Jan; 4(1):37-43. PubMed ID: 8269182
    [No Abstract]   [Full Text] [Related]  

  • 11. Heart failure: Part II.
    Wilkes MS; Middlekauff H; Hoffman JR
    West J Med; 1999 Jun; 170(6):339-42. PubMed ID: 10443162
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of the critical care nurse in preventing heart failure after acute myocardial infarction.
    Moser DK; Frazier SK; Worster PL; Clarke J
    Crit Care Nurse; 1999 Oct; 19(5 Suppl):11-5. PubMed ID: 10808807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibitor therapy: benefits and underuse.
    Smith SC
    Am Fam Physician; 1999 Jan; 59(1):35-6, 38. PubMed ID: 9917572
    [No Abstract]   [Full Text] [Related]  

  • 14. ACE inhibitors.
    Sperling RL
    Home Healthc Nurse; 2001 Jan; 19(1):47-9. PubMed ID: 11984919
    [No Abstract]   [Full Text] [Related]  

  • 15. Post infarct heart failure: what to do in addition to ACE inhibition.
    Campbell RW
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):115-8. PubMed ID: 7916201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibitors in angina and myocardial infarction. What role will they play in the 1990s?
    Ertl G
    Drugs; 1993 Aug; 46(2):209-18. PubMed ID: 7691512
    [No Abstract]   [Full Text] [Related]  

  • 17. Does the presence of heart failure alter prescribing of drug therapy after myocardial infarction?
    Bailey LJ; Naganathan V
    Med J Aust; 2007 Jan; 186(2):99-100; author reply 100-101. PubMed ID: 17223774
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure.
    McClellan MB; Loeb JM; Clancy CM; Francis GS; Jacobs AK; Kizer KW; O'Kane ME; Wolk MJ
    Ann Intern Med; 2005 Mar; 142(5):386-7; author reply 388-9. PubMed ID: 15738459
    [No Abstract]   [Full Text] [Related]  

  • 19. Issues concerning the use of angiotensin-converting enzyme inhibitors in the treatment of heart failure and myocardial infarction.
    Poole-Wilson PA
    Arch Mal Coeur Vaiss; 1994 Jun; 87 Spec No 2():35-8. PubMed ID: 7864720
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential role of mixed ACE and neutral endopeptidase inhibitor in the treatment of heart failure.
    Hu K; Ertl G
    Cardiovasc Res; 1999 Mar; 41(3):503-5. PubMed ID: 10435019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.